Login / Signup

KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?

Hannu KoistinenJaana KünnapuuMichael Jeltsch
Published in: International journal of molecular sciences (2021)
In this focused review, we address the role of the kallikrein-related peptidase 3 (KLK3), also known as prostate-specific antigen (PSA), in the regulation of angiogenesis. Early studies suggest that KLK3 is able to inhibit angiogenic processes, which is most likely dependent on its proteolytic activity. However, more recent evidence suggests that KLK3 may also have an opposite role, mediated by the ability of KLK3 to activate the (lymph)angiogenic vascular endothelial growth factors VEGF-C and VEGF-D, further discussed in the review.
Keyphrases
  • endothelial cells
  • vascular endothelial growth factor
  • prostate cancer
  • drug induced